130 related articles for article (PubMed ID: 2945270)
1. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
Sharp HK; McIlveen LP; Schuman NJ
Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
[No Abstract] [Full Text] [Related]
2. Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
Zech R; Strother SV
J Oral Maxillofac Surg; 1983 Jan; 41(1):53-6. PubMed ID: 6217303
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid.
Agrawal BL; Zelkowitz L; Hletko P
J Pediatr; 1981 Jun; 98(6):931-3. PubMed ID: 7229796
[No Abstract] [Full Text] [Related]
4. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
Iizuka A; Kuwashima M; Nagao T
Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
[No Abstract] [Full Text] [Related]
5. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
István L; Bariska I; Marton E
Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
[No Abstract] [Full Text] [Related]
6. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Zwahlen H; Beck EA
Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
[TBL] [Abstract][Full Text] [Related]
7. Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review.
Lucas ON; Albert TW
Oral Surg Oral Med Oral Pathol; 1981 Feb; 51(2):115-20. PubMed ID: 6782532
[TBL] [Abstract][Full Text] [Related]
8. Resistance to activated F IX concentrate (FEIBA).
Stenbjerg S; Jorgensen J
Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
[TBL] [Abstract][Full Text] [Related]
9. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
[TBL] [Abstract][Full Text] [Related]
10. Dental extractions in hemophilia: reflections on 10 years' experience.
Vinckier F; Vermylen J
Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):6-9. PubMed ID: 3156302
[TBL] [Abstract][Full Text] [Related]
11. Total dental extraction in a patient with F VIII inhibitor.
Stenbjerg S; Tauris P; Skottun T; Jørgensen J
Thromb Res; 1980 Jun; 18(6):889-93. PubMed ID: 6774444
[No Abstract] [Full Text] [Related]
12. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitors and "bypass" therapy in hemophilia].
Fukutake K; Fukutake K
Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
[No Abstract] [Full Text] [Related]
14. Management of dental extractions in two hemophilia A patients with factor VIII inhibitor.
Shurafa M; MacIntosh RB
J Oral Maxillofac Surg; 1987 Aug; 45(8):698-701. PubMed ID: 2956401
[No Abstract] [Full Text] [Related]
15. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
[No Abstract] [Full Text] [Related]
16. [HEMORRHAGIC DISORDERS IN HEMOPHILIA, WITH A SPECIAL REFERENCE TO FIBRINOLYSIS].
KATSUMI O
Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():788-97. PubMed ID: 14154696
[No Abstract] [Full Text] [Related]
17. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
Parry DH; Bloom AL
J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
[TBL] [Abstract][Full Text] [Related]
18. The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
Hilgartner MW; Knatterud GL
Blood; 1983 Jan; 61(1):36-40. PubMed ID: 6401216
[TBL] [Abstract][Full Text] [Related]
19. Hemophiliacs with inhibitors: therapeutic options.
Roberts HR
N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
[No Abstract] [Full Text] [Related]
20. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
